S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable

AVEVA Group Share Price, News & Analysis (LON:AVV)

GBX 3,219
+3,186.81 (+9,900.00%)
(As of 01/18/2023)
Compare
Today's Range
3,219
3,219
50-Day Range
3,219
3,219
52-Week Range
1,800
3,305
Volume
N/A
Average Volume
2.99 million shs
Market Capitalization
£9.72 billion
P/E Ratio
N/A
Dividend Yield
0.01%
Price Target
N/A

AVV stock logo

About AVEVA Group Stock (LON:AVV)

AVEVA Group plc, through its subsidiaries, provides engineering and industrial software solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company offers engineering, procurement, and construction; asset performance management; monitoring and control; planning and scheduling; and operation and optimization industrial software solutions. It also provides digital transformation solutions covering artificial intelligence, cloud, digital twin, edge, extended reality, and Industrial Internet of Things products; and customer support and training services. The company serves customers in the chemicals, food and beverage, consumer packaged goods, infrastructure, life sciences, marine, mining, oil and gas, power and utilities, pulp and paper, steel fabrication, and water and wastewater industries. The company was founded in 1967 and is based in Cambridge, the United Kingdom. AVEVA Group plc is a subsidiary of Schneider Electric SE.

AVV Stock Price History

AVV Stock News Headlines

Aveva Group Plc (LSE: AVV)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
AVV.L Regulatory News
FTSE 100 lower as Bank of Japan's surprise move sparks fear
Secure your stake in the Smart Home industry.
Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.
Aveva Group rises Wednesday, outperforms market
Dispatch of Addendum Letters to Participants in the AVEVA Share Plans
Form 8.3 - AVV LN Equity 13-November-22 Dealing Disclosure
Form 8.3 - AVV LN Equity 11-November-22 Dealing Disclosure
Dispatch of Letters to Participants in the AVEVA Share Plans
Schneider CFO says Aveva deal 'not an absolute must'
AVEVA Group plc: Form 8 (OPD) - Schneider Electric SE
See More Headlines
Receive AVV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVEVA Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Software - Application
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
6,250
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.26 billion
Cash Flow
GBX 68 per share
Book Value
GBX 1,878.30 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.72 billion
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Peter W. Herweck (Age 56)
    CEO & Exec. Director
    Comp: $1.76M
  • Mr. James Kidd (Age 53)
    Chief Strategy & Transformation Officer and Exec. Director
    Comp: $920k
  • Mr. Brian DiBenedetto
    Chief Financial Officer
  • Mr. Caspar Herzberg
    COO & Chief Revenue Officer
  • Mr. Andrew McCloskey
    CTO and Exec. VP of R&D
  • Mr. Matthew Howard Springett
    Head of Investor Relations
  • Ms. Helen Louise Lamprell
    Gen. Counsel & Company Sec.
  • Mr. Nayef Bou Chaaya
    VP of Sales & Head of Middle East and Africa
  • Ms. Caoimhe Keogan (Age 45)
    Chief People Officer
  • Mr. Amish Sabharwal
    Exec. VP of Engineering Bus.














AVV Stock Analysis - Frequently Asked Questions

How have AVV shares performed in 2023?

AVEVA Group's stock was trading at GBX 3,213 at the beginning of 2023. Since then, AVV stock has increased by 0.2% and is now trading at GBX 3,219.
View the best growth stocks for 2023 here
.

Is AVEVA Group a good dividend stock?

AVEVA Group (LON:AVV) pays an annual dividend of GBX 0.38 per share and currently has a dividend yield of 1.16%.
Read our dividend analysis for AVV.

What other stocks do shareholders of AVEVA Group own?
How do I buy shares of AVEVA Group?

Shares of AVV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AVV) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -